Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMOVE: Pharmacological Withdrawal in CRT Responders
NCT05151861Phase 4Unknown
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- Dec 2021
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in heart failure (HF) (2 arms), sponsored by Fundación para la Formación e Investigación Sanitaria. Primary endpoints: Reduction in Left Ventricular Ejection Fraction at 48 weeks, Increase in Left Ventricular End-Systolic Volume Index at 48 weeks and 1 more. Status: unknown.
02
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05151861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05151861.